Ad
related to: moderna vaccine 2nd dose
Search results
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks· 16 hours agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC's recommendation, it will be launched in the 2024-2025 respiratory virus season.
Moderna’s stock climbs on report that bird-flu vaccine funding is near
Market Watch· 4 days agoModerna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 9 hours agoIn the study, Moderna and Merck combined their cancer treatments—Moderna’s experimental cancer vaccine and Merck’s approved checkpoint ...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 3 days agoModerna stock has slumped in recent days. As concerns grow about the H5 bird flu, Moderna and fellow...
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 3 days ago"Moderna noted no incidence of GBS in Study 301 and we believe...also have a leg-up on its...
The U.S. Is Close To Bankrolling Moderna's Bird Flu Vaccine As Third Dairy Worker Tests Positive
Investor's Business Daily· 4 days agoEarly data suggests the vaccine generated "notable increases" in antibodies capable of handling the...
US government, Moderna nearing deal for bird flu vaccine funding: reports
The Hill via Yahoo News· 4 days agoThe U.S. government is reportedly close to finalizing a deal with Moderna to fund its bird flu mRNA ...
Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
Digital Journal· 3 days agomRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes CAMBRIDGE, MA / ACCESSWIRE ...
Moderna rises on FT report about bird flu vaccines By Investing.com
Investing.com· 4 days agoShares of Moderna (NASDAQ:MRNA) are up 2.8% premarket Thursday after a report from The Financial...
Moderna wins second product approval with RSV vaccine
Market Watch· 3 days agoModerna Inc.’s respiratory syncytial virus vaccine for older adults received U.S. regulatory...
